Independent trial guides doctors through epilepsy treatmentsBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7595.660-c (Published 29 March 2007) Cite this as: BMJ 2007;334:660
Patients with newly diagnosed epilepsy and their doctors have a bewildering choice of first line drugs. Navigating through them just got slightly easier with the publication of a large trial comparing the main choices head to head. Lamotrigine emerged as …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial